Review: Effects of anti-CD38 monoclonal antibodies on red blood cell transfusion and interventions.

With more and more patients receiving anti-CD38 treatment, it is of great importance to recognize this problem and optimize relevant diagnosis and treatment procedures to prevent RBC transfusion delays and reduce laboratory costs.